cytotoxic macrolides (Ryukyus)

N/A

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug Namecytotoxic macrolides (Ryukyus)
Drug Alias Namehaterumaimide Chaterumaimide Ehaterumaimide Ghaterumaimide Khaterumaimide L +[17
ClassificationNatural product/Extract
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of The Ryukyus
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A